marstacimab
SpainDrugs containing this active substance
-
It is used to prevent or reduce bleeding in patients 12 years of age or older weighing at least 35 kg who suffer from severe hemophilia A or severe hemophilia B (and who have not developed inhibitors to factors VIII or IX).
Form: solution for injection in pre-filled pen
Active substance Dosage marstacimab 150 mg Manufacturer: Pfizer Europe Ma Eeig